Florencia Bruggesser
Research Subjects
Research Interests
Florencia Bruggesser has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Jure1 shared publication
- Araceli Gitlein Zuwenger1 shared publication
- Eliana Edith Medina1 shared publication
- Erika Bartel1 shared publication
- Eva Jané-Llopis
Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, POB 616, 6200 MD Maastricht, the Netherlands; Univ. Ramon Llull, ESADE, Avenida de Pedralbes, 60, 62, 08034 Barcelona, Spain; Institute for Mental Health Policy Research, CAMH, 33 Russell Street, Toronto, ON M5S 2S1, Canada
1 shared publication - Fernanda Paredes1 shared publication
Latest Publications
- Open Access
- 11 March 2026
- Published by Elsevier in SSRN Electronic Journal
Understanding maternal vaccine acceptance in Argentina: Evidence on immunization against influenza, COVID-19, and Respiratory Syncytial Virus in 2024
BackgroundMaternal immunization is a cornerstone to protect pregnant individuals and newborns. In Argentina, the prenatal schedule includes vaccines against influenza, COVID-19, and, since 2024, respiratory syncytial virus (RSV). This study assessed behavioural and social drivers (BeSD) of acceptance for these vaccines among pregnant individuals in Argentina.MethodsWe conducted a mixed-methods cross-sectional study in seven Argentine jurisdictions from September to November 2024. A BeSD-based interviewer-administered survey was completed by 452 pregnant individuals attending prenatal care in public and private facilities. We used descriptive analyses and logistic regression models accounting for the clustered design to examine acceptance and associated factors.ResultsIntention to vaccinate was high for influenza: 349/452 (77.2%) would receive the vaccine in the next campaign; 72 (15.9%) were unsure and 31 (6.9%) did not intend to vaccinate. During the current pregnancy, 30/452 (6.6%) reported receiving a COVID-19 dose; among those not vaccinated (422), 48 (11.4%) intended to vaccinate, 258 (61.1%) were unsure, and 116 (27.5%) did not intend to vaccinate. For RSV, 25/452 (5.5%) reported vaccination in the current pregnancy, 79 (17.5%) were unsure, and 348 (77.0%) were unvaccinated; among the latter, 158 (45.4%) intended to vaccinate, 153 (44.0%) were unsure, and 37 (10.6%) did not intend to vaccinate. Health-worker recommendation is the principal positive driver for vaccination, while low risk perception, safety concerns, and lack of information were common barriers. Acceptance was associated with gestational age, parity, and educational level.ConclusionsInfluenza showed high prospective acceptance, whereas COVID-19 and RSV had low coverage in pregnancy and more uncertainty. Strengthening timely health-worker recommendations, addressing risk perception and safety concerns, and improving access to information and services may enhance maternal immunization in Argentina.
- 11 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessUnderstanding maternal vaccine acceptance in Argentina: Evidence on immunization against influenza, COVID-19, and Respiratory Syncytial Virus in 2024
BackgroundMaternal immunization is a cornerstone to protect pregnant individuals and newborns. In Argentina, the prenatal schedule includes vaccines against influenza, COVID-19, and, since 2024, respiratory syncytial virus (RSV). This study assessed behavioural and social drivers (BeSD) of acceptance for these vaccines among pregnant individuals in Argentina.MethodsWe conducted a mixed-methods cross-sectional study in seven Argentine jurisdictions from September to November 2024. A BeSD-based interviewer-administered survey was completed by 452 pregnant individuals attending prenatal care in public and private facilities. We used descriptive analyses and logistic regression models accounting for the clustered design to examine acceptance and associated factors.ResultsIntention to vaccinate was high for influenza: 349/452 (77.2%) would receive the vaccine in the next campaign; 72 (15.9%) were unsure and 31 (6.9%) did not intend to vaccinate. During the current pregnancy, 30/452 (6.6%) reported receiving a COVID-19 dose; among those not vaccinated (422), 48 (11.4%) intended to vaccinate, 258 (61.1%) were unsure, and 116 (27.5%) did not intend to vaccinate. For RSV, 25/452 (5.5%) reported vaccination in the current pregnancy, 79 (17.5%) were unsure, and 348 (77.0%) were unvaccinated; among the latter, 158 (45.4%) intended to vaccinate, 153 (44.0%) were unsure, and 37 (10.6%) did not intend to vaccinate. Health-worker recommendation is the principal positive driver for vaccination, while low risk perception, safety concerns, and lack of information were common barriers. Acceptance was associated with gestational age, parity, and educational level.ConclusionsInfluenza showed high prospective acceptance, whereas COVID-19 and RSV had low coverage in pregnancy and more uncertainty. Strengthening timely health-worker recommendations, addressing risk perception and safety concerns, and improving access to information and services may enhance maternal immunization in Argentina.